- Home
- VOR vs SEVN Comparison
VOR vs SEVN Comparison
Compare VOR & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- SEVN
- Stock Information
- Founded
- VOR 2015
- SEVN 1986
- Country
- VOR United States
- SEVN United States
- Employees
- VOR N/A
- SEVN N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- SEVN Real Estate Investment Trusts
- Sector
- VOR Health Care
- SEVN Real Estate
- Exchange
- VOR Nasdaq
- SEVN Nasdaq
- Market Cap
- VOR 202.4M
- SEVN 179.3M
- IPO Year
- VOR 2021
- SEVN N/A
- Fundamental
- Price
- VOR $2.42
- SEVN $10.89
- Analyst Decision
- VOR Buy
- SEVN Strong Buy
- Analyst Count
- VOR 7
- SEVN 3
- Target Price
- VOR $3.77
- SEVN $14.75
- AVG Volume (30 Days)
- VOR 47.5M
- SEVN 70.5K
- Earning Date
- VOR 08-07-2025
- SEVN 07-28-2025
- Dividend Yield
- VOR N/A
- SEVN 12.87%
- EPS Growth
- VOR N/A
- SEVN N/A
- EPS
- VOR N/A
- SEVN 1.15
- Revenue
- VOR N/A
- SEVN $30,074,000.00
- Revenue This Year
- VOR N/A
- SEVN $7.45
- Revenue Next Year
- VOR N/A
- SEVN $1.12
- P/E Ratio
- VOR N/A
- SEVN $9.47
- Revenue Growth
- VOR N/A
- SEVN N/A
- 52 Week Low
- VOR $0.13
- SEVN $10.18
- 52 Week High
- VOR $3.29
- SEVN $14.66
- Technical
- Relative Strength Index (RSI)
- VOR 73.52
- SEVN 34.99
- Support Level
- VOR $2.25
- SEVN $10.88
- Resistance Level
- VOR $2.84
- SEVN $12.76
- Average True Range (ATR)
- VOR 0.54
- SEVN 0.35
- MACD
- VOR 0.10
- SEVN -0.16
- Stochastic Oscillator
- VOR 70.92
- SEVN 8.08
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.